Project Grant R01EY032028
Award Date
9/1/21
Completion Date
11/22/21
Dollars Obligated
$404K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Brooklyn, NY 11203, USA
Similar Awards
The National Eye Institute (NEI) awarded a $440,806 Project Grant under the Vision Research federal grant program (CFDA 93.867) to The Research Foundation for the State University of New York (RF SUNY) to investigate the role of the molecular chaperone protein P58IPK in protecting retinal neurons from diabetic damage. The 5-year project aims to define how P58IPK regulates protein and lipid homeostasis through the integrated stress response and lipid glycosylation pathways, and evaluate the...
The National Eye Institute (NEI) has awarded a $144,362 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The award, effective September 1, 2024 through February 28, 2027, will support research to investigate the role of hyperglycemia and hyperinsulinemia in the breakdown of the blood-retinal barrier, which is a leading cause of diabetic retinopathy and preventable blindness. The...
This $439,137 Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports research at the University of Arkansas for Medical Sciences (UAMS) to investigate cellular mechanisms and therapeutic targets for retinopathies caused by ischemia or trauma, such as diabetic retinopathy, retinal artery/vein occlusion, and traumatic optic neuropathy. The research focuses on "efferocytosis", the process by which myeloid cells (macrophages/microglia) clear dead...
This $661,635 Project Grant award from the National Eye Institute (NEI), under the NEI Vision Research program (CFDA 93.867), supports research to elucidate the molecular changes in the extracellular matrix (ECM) of the outflow pathway that regulate outflow facility in steroid-induced ocular hypertension and open-angle glaucoma. The research aims to determine if ECM changes leading to tissue stiffening and reduced outflow facility are the same in open-angle glaucoma and steroid-induced...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to characterize the molecular mechanisms underlying the allosteric regulation of the REDD1 protein and its contribution to the development of diabetic retinopathy. The objective is to address knowledge gaps in understanding how diabetes-induced changes to REDD1 proteolysis lead to increased REDD1 protein abundance, which in turn drives retinal pathology. The $107,727...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), provides $387,428 to The Research Foundation For The State University Of New York to investigate mechanisms underlying optic nerve sensitivity to elevated intraocular pressure, a major risk factor for glaucoma. The key objectives are to: 1) Determine how optic nerve head astrocytes integrate transient biomechanical strains to predispose to future glaucomatous...
This federal Project Grant award, valued at $469,854 and provided by the National Eye Institute (NEI), supports research to investigate the contribution of histone deacetylase 6 (HDAC6) and sirtuin-1 (SIRT-1) to retinal vascular senescence, diabetic retinal microangiopathy, and diabetic retinopathy (DR). The award, made under the NEI's Vision Research program (CFDA 93.867), aims to validate the working hypothesis that an imbalance between HDAC6 and SIRT-1 leads to exosome-mediated retinal...
This is a Project Grant award from the National Eye Institute (NEI), part of the National Institutes of Health (NIH), under the Vision Research program (CFDA 93.867). The $451,000 award supports research by the University of Texas Southwestern Medical Center to investigate the role of the FIC enzyme in regulating the unfolded protein response (UPR) in the mammalian retina. Specifically, the project aims to determine if FIC-mediated modification of the BIP protein can modulate UPR activation,...
The National Eye Institute (NEI) awarded a $191,095 Project Grant (CFDA 93.867 - Vision Research) to the University of North Texas Health Science Center at Fort Worth. This two-year grant, effective September 1, 2024, supports research to investigate how changes in cellular metabolism and extracellular matrix signaling in the optic nerve head contribute to the development of pathological fibrosis in glaucoma. The project aims to establish the role of the YAP/TAZ transcriptional pathway in...
The National Eye Institute (NEI) awarded Vanderbilt University Medical Center a $2,305,702 Project Grant (CFDA 93.867 - Vision Research) to conduct an integrative multi-omics study to discover molecular pathways associated with diabetic retinopathy (DR). The 5-year project aims to: 1) quantify differential transcript and metabolite abundance between participants with type 2 diabetes with and without DR in the Cameron County Hispanic Cohort and replicate findings in the Hispanic Community...